Coronary Artery Disease Clinical Trials in Columbus, Ohio

9 studies are recruiting for coronary artery disease in Columbus, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Product Surveillance Registry

   The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

   Stage

   Not phased

   Ages

   Any age

   Site

   Research site, Columbus, Ohio

   Locations

   401 in total

   Run by

   Medtronic

   See if you can join NCT01524276 on ClinicalTrials.gov

2. Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

   This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasibility of the percutaneous endovascular catheter-facilitated intramyocardial delivery of XC001 in patients with RA due to obstructive CAD. Pa…

   Stage

   Phase 2

   Ages

   18 to 85

   Site

   The Ohio State University, Columbus, Ohio

   Locations

   14 in total

   Run by

   XyloCor Therapeutics, Inc.

   See if you can join NCT07048808 on ClinicalTrials.gov

3. Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

   The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercia…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   OhioHealth, Columbus, Ohio

   Locations

   19 in total

   Run by

   Supira Medical

   See if you can join NCT07296744 on ClinicalTrials.gov

4. REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

   This is a research study in women to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an o…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Ohio State University, Columbus, Ohio

   Locations

   18 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT06399692 on ClinicalTrials.gov

5. REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

   This is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Ohio State University, Columbus, Ohio

   Locations

   18 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT06399705 on ClinicalTrials.gov

6. Prevail Global Study

   The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

   Stage

   Not phased

   Ages

   18 and older

   Site

   OhioHealth Riverside Methodist Hospital, Columbus, Ohio

   Locations

   51 in total

   Run by

   Medtronic Vascular

   See if you can join NCT06535854 on ClinicalTrials.gov

7. Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

   The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Ohio State University, Columbus, Ohio

   Locations

   146 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT04124120 on ClinicalTrials.gov

8. Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

   Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…

   Stage

   Not phased

   Ages

   Any age

   Site

   Mount Carmel, Columbus, Ohio

   Locations

   72 in total

   Run by

   University of British Columbia

   See if you can join NCT04634240 on ClinicalTrials.gov

9. PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

   This purpose of this trial is to demonstrate 30 day safety and effectiveness outcomes of the KARDION CORY P4 System in subjects who require hemodynamic support during a high-risk PCI procedure.

   Stage

   Not phased

   Ages

   18 to 90

   Site

   Ohio Health Research Institute, Columbus, Ohio

   Locations

   18 in total

   Run by

   Kardion Inc

   See if you can join NCT06445608 on ClinicalTrials.gov